U.S. market Closed. Opens in 2 hours 7 minutes

AKLI | Akili, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.4300 - 0.4331
52 Week Range 0.1912 - 1.2500
Beta 3.39
Implied Volatility 333.75%
IV Rank 99.31%
Day's Volume 236,452
Average Volume 2,299,004
Shares Outstanding 78,726,704
Market Cap 34,096,536
Sector Healthcare
Industry Medical - Healthcare Information Services
IPO Date 2021-06-30
Valuation
Profitability
Growth
Health
P/E Ratio -0.71
Forward P/E Ratio N/A
EPS -0.61
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 68
Country USA
Website AKLI
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
AKLI's peers: SY, ZCMD, ACON, EUDA, WGS, MGRX
*Chart delayed
Analyzing fundamentals for AKLI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see AKLI Fundamentals page.

Watching at AKLI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AKLI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙